EPCAM and head and neck squamous cell carcinoma: Our group has previously developed a highly sensitive, specific and robust RT-qPCR assay of PD-L1 mRNA expression and we reported its clinical utility in EpCAM-positive CTCs of head and neck squamous cell carcinoma patients [36].